pentoxifylline has been researched along with Polycythemia Vera in 3 studies
Polycythemia Vera: A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sedova, GT | 2 |
| Krasiukova, LI | 2 |
| Kovaleva, LG | 2 |
| Malykhina, LS | 1 |
| Ermil'chenko, GV | 1 |
| Wahba-Yahav, AV | 1 |
3 other studies available for pentoxifylline and Polycythemia Vera
| Article | Year |
|---|---|
[Use of trental as an agent for preventing thrombus formation in patients with polycythemia vera].
Topics: Drug Evaluation; Hemostasis; Humans; Pentoxifylline; Polycythemia Vera; Recurrence; Theobromine; Thr | 1984 |
Chronic leukocytoclastic vasculitis associated with polycythemia vera: effective control with pentoxifylline.
Topics: Chronic Disease; Humans; Leg; Male; Middle Aged; Pentoxifylline; Polycythemia Vera; Vasculitis, Leuk | 1992 |
[Preventive correction of hemostasis in patients with polycythemia vera].
Topics: Aspirin; Humans; Niacin; Pentoxifylline; Polycythemia Vera; Theobromine; Thrombosis | 1986 |